Approval · Notice of Compliance 29045 · 2022
PENTHROX: Notice of Compliance 29045
Issued September 20, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29045
- Date
- September 20, 2022
- Company
- Endo Ventures Ltd
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revision to the drug substance standard from USP to professed.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PENTHROX | Not yet assigned | — |
Medicinal ingredients
- METHOXYFLURANE 99.9 PER